Pharmena S.A. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was PLN 12.87 million compared to PLN 10.78 million a year ago. Net loss was PLN 0.743 million compared to PLN 3.09 million a year ago.

Basic loss per share from continuing operations was PLN 0.07 compared to PLN 0.28 a year ago. Diluted loss per share from continuing operations was PLN 0.07 compared to PLN 0.28 a year ago.